245 related articles for article (PubMed ID: 38289032)
1. Ciprofloxacin Poly(β-amino ester) Conjugates Enhance Antibiofilm Activity and Slow the Development of Resistance.
Kasza K; Richards B; Jones S; Romero M; Robertson SN; Hardie KR; Gurnani P; Cámara M; Alexander C
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5412-5425. PubMed ID: 38289032
[TBL] [Abstract][Full Text] [Related]
2. Triblock copolymer micelles enhance solubility, permeability and activity of a quorum sensing inhibitor against
Kasza K; Soukarieh F; Romero M; Hardie KR; Gurnani P; Cámara M; Alexander C
RSC Appl Polym; 2024 May; 2(3):444-455. PubMed ID: 38800514
[TBL] [Abstract][Full Text] [Related]
3. Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate
Soukarieh F; Gurnani P; Romero M; Halliday N; Stocks M; Alexander C; Cámara M
ACS Macro Lett; 2023 Mar; 12(3):314-319. PubMed ID: 36790191
[TBL] [Abstract][Full Text] [Related]
4. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
7. Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.
Stewart PS; White B; Boegli L; Hamerly T; Williamson KS; Franklin MJ; Bothner B; James GA; Fisher S; Vital-Lopez FG; Wallqvist A
J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31501280
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
Tewes F; Bahamondez-Canas TF; Smyth HDC
AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
10. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
11. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of 3-Hydroxy-pyridin-4(1
Wang YY; Zhang XY; Zhong XL; Huang YJ; Lin J; Chen WM
J Med Chem; 2023 Feb; 66(3):2169-2193. PubMed ID: 36692083
[No Abstract] [Full Text] [Related]
13. Pharmacodynamics of ciprofloxacin against Pseudomonas aeruginosa planktonic and biofilm-derived cells.
Marques CNH; Nelson SM
Lett Appl Microbiol; 2019 Apr; 68(4):350-359. PubMed ID: 30740751
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of Pseudomonas aeruginosa Biofilm Formation and Quorum Sensing Genes in Piperacillin/Tazobactam and Ciprofloxacin Sub-minimal Inhibitory Concentrations].
Erdal B; Yalınay M; Elmas Ç; Yazıcı GN
Mikrobiyol Bul; 2020 Oct; 54(4):547-558. PubMed ID: 33107284
[TBL] [Abstract][Full Text] [Related]
15. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
[TBL] [Abstract][Full Text] [Related]
16. Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa.
She P; Wang Y; Luo Z; Chen L; Tan R; Wang Y; Wu Y
Microbiologyopen; 2018 Feb; 7(1):. PubMed ID: 29178590
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.
Carneiro VA; de Oliveira ST; Silva RL; de Sousa Duarte H; Silva ML; Matos MNC; Cavalcante RMB; Figueira CS; Lorenzón EN; Cilli EM; da Cunha RMS
Protein Pept Lett; 2020; 27(11):1124-1131. PubMed ID: 32297570
[TBL] [Abstract][Full Text] [Related]
18. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
[TBL] [Abstract][Full Text] [Related]
19. Antibiofilm activity of Fmoc-phenylalanine against Gram-positive and Gram-negative bacterial biofilms.
Singh H; Gahane A; Singh V; Ghosh S; Thakur A
J Antibiot (Tokyo); 2021 Jun; 74(6):407-416. PubMed ID: 33637856
[TBL] [Abstract][Full Text] [Related]
20. Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms.
Verderosa AD; Dhouib R; Fairfull-Smith KE; Totsika M
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
